S&P 500   2,998.47 (+0.08%)
DOW   26,810.43 (+0.08%)
QQQ   191.67 (-0.10%)
AAPL   242.39 (+1.01%)
FB   184.39 (+1.12%)
MSFT   135.93 (-0.32%)
GOOGL   1,248.50 (+0.59%)
AMZN   1,754.93 (-0.61%)
NVDA   194.83 (-0.40%)
MU   44.43 (-0.52%)
AMD   31.48 (-0.10%)
GILD   66.21 (+0.53%)
DIS   131.17 (-0.93%)
S&P 500   2,998.47 (+0.08%)
DOW   26,810.43 (+0.08%)
QQQ   191.67 (-0.10%)
AAPL   242.39 (+1.01%)
FB   184.39 (+1.12%)
MSFT   135.93 (-0.32%)
GOOGL   1,248.50 (+0.59%)
AMZN   1,754.93 (-0.61%)
NVDA   194.83 (-0.40%)
MU   44.43 (-0.52%)
AMD   31.48 (-0.10%)
GILD   66.21 (+0.53%)
DIS   131.17 (-0.93%)
Log in

Rigel Pharmaceuticals News Headlines (NASDAQ:RIGL)

$1.79
+0.10 (+5.92 %)
(As of 10/23/2019 12:12 PM ET)
Today's Range
$1.61
Now: $1.79
$1.80
50-Day Range
$1.59
MA: $1.70
$1.85
52-Week Range
$1.56
Now: $1.79
$3.29
Volume45,881 shs
Average Volume1.51 million shs
Market Capitalization$300.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

Headlines

Rigel Pharmaceuticals (NASDAQ RIGL) News Headlines

Source:
DateHeadline
Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst CallRigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call
finance.yahoo.com - October 23 at 8:32 AM
If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, Youd Be Sitting On A 42% Loss, TodayIf You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 42% Loss, Today
finance.yahoo.com - October 22 at 5:56 PM
If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 42% Loss, TodayIf You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 42% Loss, Today
finance.yahoo.com - October 22 at 5:56 PM
Cantor Fitzgerald Reiterates "Overweight" Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)Cantor Fitzgerald Reiterates "Overweight" Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)
www.americanbankingnews.com - October 22 at 7:54 AM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Buy" from BrokeragesRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 21 at 9:50 AM
Rigel Pharma not quite there with European application for fostamatinibRigel Pharma not quite there with European application for fostamatinib
seekingalpha.com - October 18 at 9:46 AM
Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in EuropeRigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
finance.yahoo.com - October 18 at 9:46 AM
Rigel to Host Investor and Analyst Call on October 23, 2019Rigel to Host Investor and Analyst Call on October 23, 2019
finance.yahoo.com - October 16 at 7:51 AM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Large Decline in Short InterestRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Large Decline in Short Interest
www.americanbankingnews.com - October 15 at 6:33 PM
Rigel Makes Progress, But Doesnt Make A Big Deal About ItRigel Makes Progress, But Doesn't Make A Big Deal About It
seekingalpha.com - October 15 at 8:59 AM
 Analysts Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Announce Quarterly Sales of $12.04 Million Analysts Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Announce Quarterly Sales of $12.04 Million
www.americanbankingnews.com - October 15 at 4:54 AM
Aclaris Divests Rhofade to EPI Health for $55M, Shares UpAclaris Divests Rhofade to EPI Health for $55M, Shares Up
finance.yahoo.com - October 14 at 12:20 PM
 Analysts Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Post Earnings of -$0.13 Per Share Analysts Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - October 13 at 7:48 AM
Rigel Secures Credit Facility for Up to $60 MillionRigel Secures Credit Facility for Up to $60 Million
finance.yahoo.com - October 2 at 5:18 PM
Kissei Pharma launches late-stage study of fostamatinib for ITP in JapanKissei Pharma launches late-stage study of fostamatinib for ITP in Japan
seekingalpha.com - September 23 at 3:46 PM
Rigels fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune ThrombocytopeniaRigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia
finance.yahoo.com - September 23 at 7:44 AM
Should You Be Concerned About Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Historical Volatility?Should You Be Concerned About Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Historical Volatility?
finance.yahoo.com - September 22 at 6:40 AM
Rigels CEO to Participate in Panel Discussion at Citis 14th Annual Biotech ConferenceRigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference
finance.yahoo.com - August 28 at 8:51 AM
Who Has Been Buying Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?Who Has Been Buying Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?
finance.yahoo.com - August 16 at 6:49 PM
Rigels Q2 Earnings Beat Provides Confidence In Commercial StrategyRigel's Q2 Earnings Beat Provides Confidence In Commercial Strategy
seekingalpha.com - August 9 at 6:57 PM
Edited Transcript of RIGL earnings conference call or presentation 6-Aug-19 8:30pm GMTEdited Transcript of RIGL earnings conference call or presentation 6-Aug-19 8:30pm GMT
finance.yahoo.com - August 7 at 5:48 PM
Rigel Pharmaceuticals Inc (RIGL) Q2 2019 Earnings Call TranscriptRigel Pharmaceuticals Inc (RIGL) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 6 at 11:44 PM
Rigel Pharmaceuticals EPS beats by $0.02, beats on revenueRigel Pharmaceuticals EPS beats by $0.02, beats on revenue
seekingalpha.com - August 6 at 6:44 PM
Rigel Announces Second Quarter 2019 Financial Results and Provides Business UpdateRigel Announces Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 6 at 6:44 PM
Rigel Announces Conference Call and Webcast to Report Second Quarter 2019 Financial ResultsRigel Announces Conference Call and Webcast to Report Second Quarter 2019 Financial Results
finance.yahoo.com - July 30 at 8:45 AM
Rigel: Competitors And CollaboratorsRigel: Competitors And Collaborators
seekingalpha.com - July 19 at 5:00 PM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?
finance.yahoo.com - July 9 at 9:37 AM
Here’s What Hedge Funds Think About Rigel Pharmaceuticals, Inc. (RIGL)Here’s What Hedge Funds Think About Rigel Pharmaceuticals, Inc. (RIGL)
finance.yahoo.com - June 24 at 5:21 PM
Rigel to Present Two Posters Highlighting Fostamatinib at the 24ᵗʰ Congress of the European Hematology Association (EHA)Rigel to Present Two Posters Highlighting Fostamatinib at the 24ᵗʰ Congress of the European Hematology Association (EHA)
finance.yahoo.com - June 13 at 12:51 PM
Rigel Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?Rigel Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - June 5 at 9:18 AM
Rigel to Present at Jefferies 2019 Healthcare ConferenceRigel to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 31 at 9:29 AM
Rigel Pharmaceuticals Inc.Rigel Pharmaceuticals Inc.
www.barrons.com - May 24 at 6:05 PM
Rigel begins patient enrollment in late-stage AHIA studyRigel begins patient enrollment in late-stage AHIA study
seekingalpha.com - May 16 at 10:58 AM
Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic AnemiaRigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia
finance.yahoo.com - May 16 at 10:58 AM
Rigel Reports An Earnings Beat, But The Market Shrugs It OffRigel Reports An Earnings Beat, But The Market Shrugs It Off
seekingalpha.com - May 11 at 9:36 AM
Rigel Pharmaceuticals, Inc. 2019 Q1 - Results - Earnings Call SlidesRigel Pharmaceuticals, Inc. 2019 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 8 at 6:42 PM
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue EstimatesRigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue Estimates
www.nasdaq.com - May 8 at 9:26 AM
Edited Transcript of RIGL earnings conference call or presentation 7-May-19 8:30pm GMTEdited Transcript of RIGL earnings conference call or presentation 7-May-19 8:30pm GMT
finance.yahoo.com - May 8 at 9:26 AM
Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call TranscriptRigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript
www.fool.com - May 8 at 2:10 AM
BerGenBio ASA: Results for the First Quarter 2019BerGenBio ASA: Results for the First Quarter 2019
www.prnewswire.com - May 8 at 1:17 AM
Rigel Pharmaceuticals beats by $0.02, beats on revenueRigel Pharmaceuticals beats by $0.02, beats on revenue
seekingalpha.com - May 7 at 6:06 PM
Rigel Announces First Quarter 2019 Financial Results and Provides Company UpdateRigel Announces First Quarter 2019 Financial Results and Provides Company Update
www.prnewswire.com - May 7 at 6:06 PM
Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company UpdateRigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update
finance.yahoo.com - April 30 at 9:21 AM
If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 40% Loss, TodayIf You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 40% Loss, Today
finance.yahoo.com - April 18 at 9:41 AM
Here's Why Rigel Pharmaceuticals Gained 17.3% in MarchHere's Why Rigel Pharmaceuticals Gained 17.3% in March
finance.yahoo.com - April 10 at 11:24 AM
Heres Why Rigel Pharmaceuticals Gained 17.3% in MarchHere's Why Rigel Pharmaceuticals Gained 17.3% in March
www.fool.com - April 9 at 8:58 PM
Rigel Welcomes Jane Wasman to Board of DirectorsRigel Welcomes Jane Wasman to Board of Directors
finance.yahoo.com - March 26 at 9:39 AM
Rigel Pharmaceuticals IncRigel Pharmaceuticals Inc
www.bloomberg.com - March 19 at 9:47 AM
Is Rigel Pharmaceuticals, Inc.’s (NASDAQ:RIGL) CEO Overpaid Relative To Its Peers?Is Rigel Pharmaceuticals, Inc.’s (NASDAQ:RIGL) CEO Overpaid Relative To Its Peers?
finance.yahoo.com - March 12 at 5:59 PM
Edited Transcript of RIGL earnings conference call or presentation 28-Feb-19 10:00pm GMTEdited Transcript of RIGL earnings conference call or presentation 28-Feb-19 10:00pm GMT
finance.yahoo.com - March 4 at 6:35 PM
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel